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ORIGINAL RESEARCH ARTICLE
mated to be 64 million, increasing to 76 million in 2020 and 
112 million in 2040 (1, 2). Glaucoma paients require lifelong 
review to monitor their condiion and response to eye pres-
sure-lowering treatments. As the populaion ages, glaucoma 
will coninue to present a signiicant burden for our current 
healthcare resources (3). One strategy for an improvement 
in paient outcomes is to increase paients’ knowledge and 
understanding of their disease, to in turn enhance treatment 
compliance and reduce disease-related morbidity.
There are various paient-held care records uilized in 
various UK healthcare services (4-6), but as yet such records 
have not been available for glaucoma paients. Previous re-
search recognizes that clients who receive emoional support 
and informaion at the iniial diagnosis of glaucoma beneit 
by subsequently displaying good compliance and coopera-
ion with their care (7, 8). The NICE Guideline Development 
Group made recommendaions for research into the clinical 
efeciveness of providing people with glaucoma with a glau-
coma personal record (GPR) and for this to be compared to 
standard treatment (9). Clinical teams may provide numerous 
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Introducion
Glaucoma encapsulates a disparate group of eye diseases 
that are mulifactorial and individual to each paient. The 
common factor is progressive opic nerve iber loss, which 
leads to irreversible and disabling visual ield defects if it 
is not diagnosed and treated early. In 2013, the worldwide 
number of people (age 40-80 years) with glaucoma was esi-
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resources to paients, depending on the individuals’ speciic 
needs, yet there is potenial to produce a standardized sum-
mary that can be tailored to record each individual’s current 
appearance of his or her own glaucoma status. This summary 
should have the potenial to add value to paient care as it 
would be held by each individual, and be personalized to re-
lect his or her own condiion.
Recent work by Waterman (10) ideniied the need for pa-
ients to be beter informed about their glaucoma, to help 
them understand their condiion and the health implicaions 
of poor medicaion adherence. To this efect, Spaeth and Pau-
lus (11) developed a colored glaucoma graph for diagnosed 
glaucoma paients and glaucoma suspects; it provides both 
paients and clinicians with visual informaion concerning 
current opic disc appearance. Its simple traic light system 
was extended to other outcome measures, such as visual 
ield scoring using the Hoddap Classiicaion (12, 13) and in-
traocular pressure measurement.
This study aims to fulil the NICE requirement by assessing 
the clinical efeciveness of providing paients with ocular hy-
pertension (OHT), suspected glaucoma (SG), or chronic open-
angle glaucoma (COAG) (henceforth collecively referred to 
as glaucoma) with an in-house-developed GPR, applying the 
earlier menioned visually eicient graphs for clinical param-
eters, in comparison to current standard best pracice. Here 
we focus on the primary objecive of the trial, an evaluaion 
of glaucoma paients’ knowledge at 1 year following receipt 
of a GPR compared to knowledge of paients who receive 
standard clinical care.
Methods
Trial design and subjects
This prospecive, single-center, parallel-group, random-
ized, controlled clinical trial recruited 122 adults, newly diag-
nosed with glaucoma (including OHT, SG, and/or COAG), from 
a nurse-led ophthalmology outpaient clinic at a medium-sized 
NHS Trust in the United Kingdom. Naional ethics approval, 
reference 12/YH/0471, and local insitute approval were ob-
tained prior to commencing the trial. The study is registered 
with the Internaional Standard Randomized Controlled Trial 
Number Registry, reference ISRCTN41306818. The degree of 
standard paient educaion and informaion provision within a 
specialist nurse clinic consists of paients being shown an en-
larged model of the eye and ocular anatomy posters, ocular 
coherence tomography sample scans, and images of healthy 
and damaged opic nerve heads. Furthermore, the nurse 
shows examples of normal visual ield tests and those show-
ing glaucomatous loss, and paients are ofered a generic Trust 
glaucoma informaion lealet to take. The lealet is based on 
widely available lealets, from, e.g., Royal Naional Insitute for 
the Blind, and covers the deiniion of glaucoma, its treatment, 
diagnosic tests, and further contacts. This is the standard 
clinical pracice intervenion for the control group, and also 
for those in the intervenion arm, who received the addiional 
GPR booklet with more personal clinical informaion and fur-
ther explanaions on the impact of certain diagnosic readings.
The main inclusion criteria were English-speaking adults 
with intact mental capacity who had just received a new 
 diagnosis of OHT, SG, or COAG or any combinaion of OHT, 
SG, COAG, or primary/secondary glaucoma. Paients fulill-
ing the trial eligibility criteria were recruited and random-
ized at a baseline clinic visit, to avoid a priming efect.
Outcome measures
The trial methodology has been described in detail in a 
previous publicaion that outlines the protocol (14). In sum-
mary, the Health of Paients’ Eyes (HOPE) trial is designed to 
ascertain if a GPR will improve glaucoma paients’ knowledge 
of their condiion at 1-year follow-up (primary outcome) and 
if it will alter clinical outcomes at long-term follow-up ap-
pointments at 2 and 3 years (secondary outcome). During the 
baseline visit and 1-year follow-up visit, clinical parameters 
were collated: opic disc damage (disc damage likelihood 
scale), visual ield score, and eye pressure. The 25-item Na-
ional Eye Insitute Visual Funcion Quesionnaire (VFQ-25) 
was also administered to obtain a paient-reported outcome 
measure of quality of life related to glaucoma (15). Dur-
ing the 1-year follow-up visit, a knowledge assessment was 
conducted by the chief invesigator. This quesionnaire was 
devised and validated by Gray and colleagues (15). Depend-
ing on whether a paricipant is prescribed anihypertensive 
eyedrops or not, he or she can score a maximum of 17 or 
12 points based on 10 or 6 quesions, respecively. The ques-
ions relate to knowledge concerning the pathology of glau-
coma, its efect on vision, means to invesigate glaucoma, 
and, for anihypertensive eyedrop users, the mode of acion 
of the medicaion and instrucions for use. The clinical pa-
rameters, and VFQ-25, are planned to be measured again at 
2 and 3 years ater the irst baseline visit as part of the HOPE 
glaucoma trial.
Intervenion development and evaluaion
The GPR was devised with the intenion to produce an 
afordable yet funcional 16-page A5 booklet containing per-
sonalized informaion concerning a paient’s glaucoma condi-
ion; the booklet used has been published previously (14). It 
was reined with advice from a small sample of glaucoma pa-
ients and input from the Internaional Glaucoma Associaion. 
Traic light systems are uilized to educate the paient on key 
clinical parameters: visual ield loss, intraocular pressure, disc 
damage likelihood scale, and disc damage (with explanatory 
footnotes included). The paient’s glaucoma care plan is also 
summarized in the booklet (11). In addiion to the methods 
described in Forbes and colleagues (14), feedback was sought 
on the intervenion by the development of a 5-quesion sur-
vey, consising of 4-point Likert answer opions, which was 
posted to all paricipants randomized to receive the GPR ater 
the year 1 follow-up appointment.
Analysis
Accouning for a 20% dropout rate, the study was de-
signed to have 90% power to detect a 12% diference in pa-
ient knowledge of glaucoma between the 2 arms. Diferences 
in distribuion (e.g., paient age, sex, level of educaion) were 
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For assessing diferences between the control and interven-
ion groups in terms of the level of knowledge demonstrated, 
2-sided Mann-Whitney U test was applied. Mulilinear regres-
sion was used to analyze which factors are signiicantly associ-
ated with either reduced or enhanced glaucoma knowledge. 
Due to the chronic nature of glaucoma, clinical outcome mea-
sures cannot be compared between the 2 arms due to the 
short duraion of follow-up (12 months).
Results
A total of 122 paricipants were recruited; distribuion of 
paients into the 2 treatment arms was as follows: n = 69 for 
the control arm and n = 53 for the intervenion arm. Paient 
eligibility, recruitment, and retenion through the study are 
presented in a CONSORT low diagram (Fig. 1). The 2 trial 
arms were compared in terms of paricipant demographics, 
use of prescribed anihypertensive eyedrops, and the iniial 
diagnosis at presentaion. Table 1 shows that there are no 
pronounced diferences in average age, sex distribuion, aver-
age educaional level achieved, or type of diagnosis between 
the control arm and intervenion (GPR) arm.
The primary outcome measure, paients’ knowledge 
of glaucoma, was quaniied using a validated researcher- 
conducted survey at 12 months postrecruitment on average 
(16). Since the total available score is 12 for those not pre-
scribed anihypertensive drops and 17 for those prescribed 
eyedrops during the course of the study, the achieved scores 
were converted into a percentage score with a maximum of 
100%. Table 1 and Figure 2 demonstrate that GPR provision 
does not lead to a staisically signiicant diference in knowl-
edge when compared to scores achieved by the paients in 
the control arm.
TABLE I -  Characterisics of paricipants in the control and interven-
ion arms




Median age, y 65 65
Male/female 31/26 25/19




Use of prostaglandin analog  






 Glaucoma suspect 26 (15) 18 (8)
 Open-angle glaucoma 26 (15) 27 (12)
 Ocular hypertension 25 (14) 34 (15)
 Suspicious discs 2 (1) 5 (2)
 Other 2 (1) 0 (0)
 Muliple diagnoses 19 (11) 16 (7)
Visual ield R, median -2.14 -2.37
Visual ield L, median -2.31 -2.76
Eye pressure R, median 22.0 22.0
Eye pressure L, median 22.0 22.0
Q1, VFQ-25, median 75 63
Q2, VFQ-25, median 80 80
Q3, VFQ-25, median 75 88
Q10, VFQ-25, median 100 100
Median knowledge score for validat-
ed quesionnaire, % (see also Fig. 2)
58 53
aOpions were 0, primary school; 1, O-level/GCSE; 2, A-level; 3, vocaional 
training; 4, college; 5, university.
Fig. 1 - CONSORT low diagram: Health of Paients’ Eyes (HOPE) 
glaucoma. Summary of number of paients involved in diferent 
stages of the HOPE trial.
Fig. 2 - Glaucoma knowledge scoring. Box-and-whisker plot high-
lighing the minimum and maximum values (end of whiskers), 25th 
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Since knowledge levels may be dependent on various 
factors, muliple linear regression was applied to determine 
which factors may contribute to reduced or enhanced knowl-
edge among paients. Table II shows that age is negaively 
associated with knowledge (i.e., older age is associated with 
less knowledge). Conversely, a higher level of educaion is as-
sociated with increased knowledge of glaucoma. No other 
variables were signiicantly associated with a change in glau-
coma health literacy.
A postal survey, sent only to paricipants in the booklet 
arm approximately 1 year ater they irst entered the trial and 
received the booklet at baseline visit, explored how the par-
icipants perceived the GPR intervenion. Five quesions cov-
ered topics around the usefulness and impact of the GPR, or 
HOPE paient booklet, as it was called in the survey. Table III 
summarizes the results and shows that the feedback on the 
GPR was very posiive. The response rate for this survey ele-
ment of the study was 57% (25/44 respondents). Paricipants 
were also invited to add free text comments. Twelve of the 
15 paients providing such feedback gave posiive feedback, 
e.g., “The feedback was helpful to my opician when check-
ing my eyes” and “The booklet was clear, concise, and easy to 
understand.”
Discussion
The HOPE glaucoma study consitutes the irst efort to-
wards fulilling NICE recommendaions for research into the 
clinical efeciveness of providing people with COAG with a GPR 
when compared with standard treatment (9). Three outcomes 
are deduced from this trial: (1) the GPR used in its present for-
mat and with current contents does not enhance a glaucoma 
paient’s knowledge of glaucoma; (2) despite a lack of eicacy 
in terms of paients’ knowledge, the GPR is valued and recom-
mended by those who were allocated the booklet; (3) the key 
variables that signiicantly inluence a paient’s likely (lack of) 
knowledge of glaucoma are age and level of educaion.
The content of the GPR was developed using validated 
tools published previously, and a balanced approach was 
taken to include visual informaion and text. Extended use of 
text was avoided to minimize the size of the booklet and to 
make the booklet as inclusive as possible for those paients 
who are less health literate. One could quesion whether too 
litle in-depth informaion about glaucoma was included in 
the GPR, and if this therefore diminished the potenial edu-
caional impact of the intervenion. There is a possibility that 
the current standard educaion received by newly diagnosed 
glaucoma paients in a specialist nurse clinic is already ex-
tensive, and that this may therefore limit any impact that a 
the GPR may have on a paient’s knowledge of the condi-
ion. However, contrary to the one-of educaion received 
by paients when newly diagnosed with glaucoma, the GPR 
features in the  follow-up visits, and therefore may have a 
more long-term posiive impact not measured in the 1-year 
follow-up visit. Longer-term follow-up of the HOPE glaucoma 
trial paients at 2 and 3 years will further assess this in terms 
of clinical outcomes. The trial included the use of a control 
group, random allocaion of the GPR, allocaion concealment 
to minimize selecion bias, and the use of validated quesion-
naires to capture knowledge outcome data. Upon analysis 
of the data, we can conclude that on average the paients in 
the 2 trial arms had similar baseline characterisics, with no 
marked diferences detected in levels of educaion, age, sex, 
type of glaucoma, or degree of prescripion of prostaglandin 
analogs. The sample size was such that the trial was ade-
quately powered to detect a small (12%) diference in knowl-
edge between the 2 arms. Against these strengths, the trial 
TABLE III -  Results of paient saisfacion survey concerning glau-
coma personal record
Quesions and response opions Paricipant response
Median Mode Range
How would you rate the overall usefulness 
of the personalized HOPE paient booklet? 
(1 Not at all useful/2 not very useful/3 fairly 
useful/4 very useful)
4 4 3-4
Do you feel that the overall booklet was 
it for its purpose (appropriate number of 
pages, easy to read, logical layout)? (1 Not 
at all/2 a litle/3 somewhat/4 very much so)
4 4 2-4
Did the personalized HOPE paient book-
let help you understand your glaucoma 
condiion beter? (1 Not at all/2 a litle/3 
somewhat/4 very much so)
4 4 1-4
Did the personalized HOPE paient book-
let make you look for, or use, other re-
sources (lealets, websites) to learn more 
about your glaucoma? (1 Not at all/2 a 
litle/3 somewhat/4 very much so)
3 1 1-4
Would you recommend the personalized 
HOPE glaucoma booklet to others? (1 Not 
at all/2 a litle/3 somewhat/4 very much so)
4 4 2-4
HOPE = health of paients’ eyes.




Allocaion (control or intervenion) -0.058 0.77
Age -0.24 0.015a
Level of educaion 0.32 0.002a
Sex 0.002 0.99
Diagnosis, type of glaucoma -0.039 0.68
Use of eyedrops -0.057 0.55
Booklet returned or not -0.14 0.45
Q1, VFQ-25, baseline (general health) 0.083 0.44
Q2, VFQ-25, baseline (eye health) 0.072 0.50
Q3, VFQ-25, baseline (eye health concern) -0.023 0.82
Q10, VFQ-25, baseline (peripheral vision) -0.18 0.068
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was conducted in one center only in a rural locaion, covering 
a highly  homologous white Briish populaion. Furthermore, 
blinding of the assessor was not possible due to the trial de-
sign and this may introduce detecion bias. The beneit of a 
single center meant that only one invesigator delivered the 
invenion and knowledge test, diminishing the risk of inter-
rater variability.
The results of our trial paricipant survey of those in 
receipt of a GPR indicate that overall the intervenion is 
welcomed by glaucoma paients. However, despite parici-
pants’ opinion that the GPR helped them understand their 
glaucoma beter, this did not translate into higher knowl-
edge scores compared to standard care paients. This may to 
some extent be explained because GPR paients did not go 
beyond reading the booklet, such as exploring the Internet 
for sources of informaion. Potenial issues with the survey 
are that nonresponders may have a less posiive opinion, or 
be less interested in the concept of a GPR, but this is not 
recorded. Even among the survey responders, 10% of the 
paients who received the GPR menioned that they did not 
recall receiving it. A small sample was canvassed in the sur-
vey and there is potenial for an unquaniied bias to be in-
troduced due to a response rate of only just over 50%. One 
factor that may mask the knowledge inluence by the GPR is 
that both groups were sill exposed to educaional resourc-
es and materials presented at diagnosis as part of standard 
clinical pracice, as summarized in Methods. In terms of po-
tenial for opimizaion of GPR delivery, this trial already of-
fered and delivered support and educaion to paients at the 
ime of diagnosis, the most opportune moment (7). How-
ever, there may have been scope for reinforcement of the 
educaional message; for example, 3 months ater the base-
line visit, via a telephone conversaion, or through closer col-
laboraion with community opicians and other ophthalmic 
clinical staf. The core aim of this trial was to improve health 
literacy among glaucoma paients through the provision of 
printed (personal) health informaion, as suggested by NICE. 
Numerous diferent health literacy educaion opions are 
available (17, 18). When compared to other types of edu-
caional intervenions, the anicipated posiive efect of GPR 
is not expected to be as high as one-to-one or group inter-
venions (19), although the former is mostly likely the most 
economical to deliver.
In this trial, GPR did not signiicantly improve glaucoma 
knowledge. A paient’s level of achieved educaion did cor-
relate posiively with an increased level of knowledge on 
glaucoma, and this has been observed previously by others 
(19, 20). Since the trial arms were well-balanced in terms of 
average level of educaion achieved, this is unlikely to have 
confounded our results. The negaive correlaion of age with 
glaucoma knowledge pinpoints the need for more tailored 
health educaion in glaucoma management. In line with ob-
servaions from other studies, a more intense support pro-
gram is required for elderly paients and those with a low 
socioeconomic status to opimize individuals’ adherence 
to glaucoma treatment (20, 21). More long-term follow-up 
of paricipants in this HOPE trial will determine if glaucoma 
knowledge—known to improve medical adherence (22)—or 
other factors ideniied here such as paient level of educa-
ion may impact on glaucoma progression.
Conclusion
The use of a GPR, in the format used in this trial, is not 
an efecive addiional source of informaion to enhance pa-
ients’ knowledge of glaucoma. The GPR does not impact on a 
paient’s knowledge of glaucoma in either a posiive or nega-
ive way. Age-speciic intervenions and support programs, 
and educaional support aimed at those glaucoma paients 
who are less health literate, need to be considered to opi-
mize their efeciveness. 
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